Periodic Review in Pharmaceutical GMP Systems

Learn how to perform effective periodic reviews in pharmaceutical GMP, including scope, quality data, risk assessment, documentation and compliance.
The periodic review is an essential part of a suitable Pharmaceutical Quality System. It allows examining the ongoing processes and understanding if a process, equipment, system, document or validated system still performs according to the requirements.
Periodic Review
In pharmaceutical production, problems arise not as a result of one major malfunction but are developed over time through continuous failures, maintenance issues, calibration problems, OOS results, process trends or repeated corrective actions. The periodic review combines numerous pieces of information into evidence suitable for evaluation of the systems or processes and their performance.

Well-organized periodic review is not just a formality but rather a management technique that allows evaluating quality deterioration, assessing control and taking required measures to strengthen control.

What is a periodic review?

A periodic review is a documented assessment done at predetermined intervals to establish whether a system, process, equipment, documentation or another GMP element is still fit for its intended use.

Depending on the subject of the review, the assessment could include:
  • Deviations
  • CAPA
  • Change control
  • Out of Specification (OOS) and Out of Trend (OOT) results
  • Complaints
  • Calibration history
  • Preventive maintenance
  • Environmental monitoring
  • Validation state
  • Audit findings
  • Regulatory changes
  • Previous review outcomes
  • Performance trends
The scope should be appropriate to the risk and significance of the reviewed object.

Why Regular Reviews are Necessary

The main aim is to identify decline or potential risk. An apparatus is capable to keep functioning effectively but at the same time is starting the process of losing the original control system.

Regular reviews can identify:
  • High number of equipment malfunctions
  • Continuing deviations
  • Grown maintenance need
  • Process fluctuation
  • Obsolete procedures
  • Poor control
  • Gaps in validation
  • Frequent laboratory failures
  • Ongoing CAPA effectiveness problem
So the review plays the role of health check of the pharmaceutical quality system.

What Should be Included in the Review?

The review shall be based on the established procedure or review plan.
For important pieces of equipment, the focus of the review can be on:
1. Testing outcome: To check if the equipment has always complied with the requirements of testing.
2. Maintenance record: To analyze the instances of breakdowns, corrective maintenance, repairs and malfunctions of equipment.
3. Deviations: To find out if it is possible to record deviations related to equipment operation.
4. Changes: To trace all modifications of the equipment or its software, operating conditions or procedures operated with these pieces of equipment.
5. Qualification status: To check whether qualification is still valid and if all the necessary corrections are made in this field.
6. Performance indicators: To look for signs of deterioration of equipment performance.

In the case of a review for processes, it is more likely for the process to emphasize performance of a batch, process capability, deviations, OOS results, yield trends, complaints and the data on continuous process verification.

Periodic Review of Documents

It is necessary to carry out periodical assessment of all GMP documents. However, the evaluation should not only check whether any given document has reached its review date but rather whether the content remains relevant.

In particular, the evaluator must seek answers to the following questions:
  • Did the process change?
  • Did equipment change?
  • Did the regulations change?
  • Did the deviations indicate deficiencies?
  • Did the audit confirm the deficiencies?
  • Are the instructions still correct?
  • Does the procedure comply with factual actions?
If the procedure is deemed inappropriate in any way, it has to enter the document updating process. A document cannot be kept as it is only because nothing has happened since it was last assessed.

Periodic Review of Validated Systems

Validation-performed regular reviews are very significant for computer and critical GMP systems.

The review includes:
  • Modifications on the system
  • Incidents
  • Deviation
  • Changes in access control
  • Audit trail concerns
  • Backup recovery and performance
  • Events related to security
  • Management of users
  • System upgrades
  • The state of being validated
The objective of this is to find out whether the current evidence supports a validated state. With respect to computer systems, regular review may also indicate whether the initial validation assumptions are still valid as the system changes over time.

How to Conduct an Effective Review

An effective review can be carried out in simply a few steps as follows:

1. Determine the Time Frame of Review

It should be specified beforehand what period will be analyzed, e.g., past year.

2. Gather Required Information

Collect all quality and operational data relevant to the process/system.

3. Analyze Patterns

It is not sufficient to merely enumerate events. It is important to look for the patterns.

For example, if the same component has experienced three minor failures, it can indicate the problem with the system as a whole.

4. Evaluate Risks

It should be decided whether observed trends may have impact on the quality of products, safety, data integrity, of regulatory compliance.

5. Define Actions

In case any weaknesses have been uncovered proper actions should be identified, e.g. corrective and preventive actions, preventive maintenance, retraining, change control, requalification or document changes.

6. Confirm the Review

The final assessment should be verified and approved by the authorized personnel.

Periodic Review Should not Become a Checklist

The periodic review should not simply be perceived as a checklist task.

A review may record:
  • Deviations reviewed
  • CAPA reviewed
  • Changes reviewed
  • Calibration reviewed
and conclude that everything is working fine.

However, there is a major issue in that merely confirming that records were reviewed does not mean they were actually analyzed. Stronger reviews describe what information indicates.

For example,
“During the review period, calibration was done four times. All the instruments were in compliance with the acceptance criteria with no observed trend. There was no effect on the quality of the product.”

This conclusion is much better than just saying that “calibration was reviewed.”

Frequency of Periodic Review

This paragraph talks about how often periodic reviews should happen.

Factors affecting frequency includes:
- Importance
- Requirements
- Past performance
- Number of changes
- Effect of product
- Complexity of systems
- History of failures
The review of important computer systems should be different from that of systems with low risks. The organization should determine the frequency using written procedures.

Common Periodic Review Deficiencies

Common weaknesses identified in audits include:
  • Reviews done late
  • The criteria for reviews not stated clearly
  • Definition of trends not conducted in sufficient depth
  • Lack of supporting evidence for conclusions
  • Issues that have been noted repeatedly with no small errors in the past
  • No assessment of efficacy of corrective actions
  • Allows to use regulatory changes not being assessed
  • Using practices providing insufficient expertise in reviews
  • The assessment not being confirmed by data
  • Periodic review that is mere formality
The most pressing issue is repetitive conclusions by years with no evidence.

Making Periodic Reviews More Valuable

Organizations can make their review systems better by linking the review system to the Pharmaceutical Quality System.

Various helpful techniques include:
  • Adopting risk-oriented review criteria.
  • Analyzing and monitoring trends rather than just reporting specific events.
  • Reviewing current performance in previous review periods.
  • Recognizing common weaknesses.
  • Linking key results to CAPA or to the change control system.
  • Reviewing findings of past activities.
  • Formulating unambiguous conclusions.
  • Reporting significant information to the management.
The reviewer must approach the task as a technical evaluation rather than as an administrative one.

A periodic review is a useful tool for verifying that pharmaceutical processes, equipment, systems and documents remain in a state of control and compliance.

However, how the information is interpreted determines its usefulness. Collecting documents and filing them does not give the same level of assurance as an evaluation of the trends, risk assessment and verification that any previous problems have been sufficiently addressed.

The key periodic review should provide answers to three questions:
  • What happened during the review period?
  • How do the trends look?
  • Is there anything that needs to be done?
When these questions are addressed with the use of objective evidence, periodic review becomes a valuable early-warning device for Pharmaceutical Quality System. It can bring to light deterioration, repeating problems, outdated controls and new risks before they evolve into major compliance failures or product quality problems.






is a prominent Pharmaceutical Quality Assurance expert, consultant and the founder of Pharmaguideline. With over 22 years of hands-on experience in cGMP-compliant manufacturing environments, he specializes in establishing validation protocols, sterile area controls and data integrity systems. Ankur routinely interprets international regulatory frameworks (including FDA, EMA and ICH guidelines) to help global pharmaceutical professionals ensure strict regulatory compliance and operational excellence. Connect with Ankur on LinkedIn. Need Help: Ask Question

No comments:

Post a Comment

Please don't spam. Comments having links would not be published.